AN

ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.

Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.

ANGEN | IS

Overview

Corporate Details

ISIN(s):
TREANGN00010 (+1 more)
LEI:
789000SFK2PSN72IVM96
Country:
Türkiye
Address:
İSTANBUL PLAZA KASAP İSMAİL SOK.NO.10/22-23, 34722 ISTANBUL
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Anatolia Geneworks is a biotechnology company specializing in the research, development, and manufacturing of molecular diagnostic solutions. The company's core expertise lies in Real-Time PCR (qPCR) technology. Its primary product line, the Bosphore® series of qPCR kits, enables the rapid and accurate detection of various pathogens causing infectious diseases, including sexually transmitted diseases, sepsis, gastroenteritis, and hepatitis. To support diagnostic workflows, the company also develops and manufactures the UNIO® family of automated robotic systems for nucleic acid isolation and PCR setup. By providing both advanced diagnostic kits and integrated automation systems, Anatolia Geneworks offers a comprehensive solution for clinical and research laboratories worldwide, aiming to improve testing efficiency and diagnostic outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-31 16:10
Annual / Quarterly Financial Statement
Sorumluluk Beyanı
Turkish 22.1 KB
2025-10-31 16:10
Management Discussion and Analysis
Faaliyet Raporu
Turkish 813.2 KB
2025-10-31 16:10
Report Publication Announcement
Faaliyet Raporu
English 11.1 KB
2025-10-31 16:10
Quarterly Report
Financial Report
English 1.4 MB
2025-10-31 16:10
Quarterly Report
Financial Report
Turkish 1.1 MB
2025-10-31 16:10
Quarterly Report
Financial Report
English 2.5 MB
2025-09-30 17:14
Share Issue/Capital Change
Company General Info Form
English 7.3 KB
2025-09-30 17:13
Board/Management Information
Mali İşler Direktörünün Görevinden Ayrılması Hk.
English 17.0 KB
2025-09-09 17:10
Environmental & Social Information
Participation Finance Principles Information Form
English 53.1 KB
2025-09-08 17:10
Environmental & Social Information
Participation Finance Principles Information Form
English 53.1 KB
2025-08-19 12:04
Registration Form
Esas Sözleşme Hk.
Turkish 205.2 KB
2025-08-19 12:04
Registration Form
Esas Sözleşme Hk.
English 22.2 KB
2025-08-19 12:04
Registration Form
Kayıtlı Sermaye Tavanına İlişkin Esas Sözleşme Maddesi Tadilinin Tescili Hk.
Turkish 1.2 MB
2025-08-19 12:04
Share Issue/Capital Change
Kayıtlı Sermaye Tavanına İlişkin Esas Sözleşme Maddesi Tadilinin Tescili Hk.
English 6.6 KB
2025-08-19 12:01
Post-Annual General Meeting Information
Bağımsız Denetim Şirketinin Tescili Hk.
Turkish 28.9 KB

Automate Your Workflow. Get a real-time feed of all ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.